Harris Todd 4
4 · Tyra Biosciences, Inc. · Filed Oct 17, 2024
Insider Transaction Report
Form 4
Harris Todd
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2024-10-16$25.22/sh−4,900$123,556→ 1,462,438 total - Sale
Common Stock
2024-10-17$26.37/sh−200$5,274→ 1,418,647 total - Sale
Common Stock
2024-10-16$26.98/sh−3,922$105,811→ 1,434,041 total - Sale
Common Stock
2024-10-15$24.31/sh−10,035$243,970→ 1,467,338 total - Sale
Common Stock
2024-10-16$26.23/sh−24,475$642,062→ 1,437,963 total - Sale
Common Stock
2024-10-17$25.84/sh−15,194$392,598→ 1,418,847 total
Footnotes (6)
- [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022.
- [F2]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $24.00 to $24.8667. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F3]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $24.72 to $25.59. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F4]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $25.78 to $26.78. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F5]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $26.79 to $27.08. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F6]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $25.30 to $26.16. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.